Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 350261 - 350280 out of 495978 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Poland | (L01EX01) sunitinib | Sutent, kaps. twarde, 12,5 mg | 28 szt., 12,5 mg , 28 kaps. | Wholesale price with vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors; Carcinoma, Renal Cell; Neuroendocrine Tumors | PfizerEuropeMAEEIG |
| Poland | (L01EX01) sunitinib | Sunitinib Teva, kaps. twarde, 25 mg | 28 szt. (blister), 25 mg , 28 kaps. w blistrze perforowanym | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | TevaB.V. |
| Poland | (L01EX01) sunitinib | Sutent, kaps. twarde, 25 mg | 28 szt., 25 mg , 28 kaps. | Wholesale price with vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors; Carcinoma, Renal Cell; Neuroendocrine Tumors | PfizerEuropeMAEEIG |
| Poland | (L01EX01) sunitinib | Sunitinib Teva, kaps. twarde, 50 mg | 28 szt. (blister), 50 mg , 28 kaps. w blistrze perforowanym | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | TevaB.V. |
| Poland | (L01EX01) sunitinib | Sutent, kaps. twarde, 50 mg | 28 szt., 50 mg , 28 kaps. | Wholesale price with vat |
$0-0 |
$0-0 |
Gastrointestinal Stromal Tumors; Carcinoma, Renal Cell; Neuroendocrine Tumors | PfizerEuropeMAEEIG |
| Poland | (L01EX02) sorafenib | Sorafenib Pharmascience, tabl. powl., 200 mg | 112 szt., 200 mg , 112 tabl. | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | PharmascienceInternationalLimited |
| Poland | (L01EX02) sorafenib | Sorafenib Teva, tabl. powl., 200 mg | 112 szt. (blister), 200 mg , 112 tabl. w blistrze perforowanym | Wholesale price with vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsPolskaSp.zo.o. |
| Poland | (L01EX09) nintedanib | Vargatef, kaps. miękkie, 100 mg | 60 szt., 100 mg , 60 kaps. | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | BoehringerIngelheimInternationalGmbH |
| Poland | (L01EX12) larotrectinib | Vitrakvi, roztwór doustny, 20 mg/ml | 2 butelki 50 ml, 20 mg/ml , 2 butelki 50 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerAG |
| Poland | (L01FA01) rituximab | Ruxience, koncentrat do sporządzania roztworu do infuzji, 100 mg | 1 fiol.po 10 ml, 100 mg , 1 fiol. 10 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell; Arthritis, Rheumatoid; Microscopic Polyangiitis; Pemphigus | PfizerEuropeMAEEIG |
| Poland | (L01FA01) rituximab | Ruxience, koncentrat do sporządzania roztworu do infuzji, 500 mg | 1 fiol.po 50 ml, 500 mg , 1 fiol. 50 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell; Arthritis, Rheumatoid; Microscopic Polyangiitis; Pemphigus | PfizerEuropeMAEEIG |
| Poland | (L01FD01) trastuzumab | Kanjinti, proszek do sporządzania koncentratu do przygotowania roztworu do infuzji, 150 mg | 1 fiolka po 20 ml, 150 mg , 1 fiol. 20 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | AmgenEuropeB.V. |
| Poland | (L01FD01) trastuzumab | Kanjinti, proszek do sporządzania koncentratu do przygotowania roztworu do infuzji, 420 mg | 1 fiolka po 50 ml, 420 mg , 1 fiol. 50 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | AmgenEuropeB.V. |
| Poland | (L01FF01) nivolumab | Opdivo, koncentrat do sporządzania roztworu do infuzji, 10 mg/ml | 1 fiol.po 4 ml, 10 mg/ml , 1 fiol. 4 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Mesothelioma; Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG |
| Poland | (L01FF01) nivolumab | Opdivo, koncentrat do sporządzania roztworu do infuzji, 10 mg/ml | 1 fiol.po 10 ml, 10 mg/ml , 1 fiol. 10 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Mesothelioma; Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG |
| Poland | (L01FF02) pembrolizumab | Keytruda, koncentrat do sporządzania roztworu do infuzji, 25 mg/ml | 1 fiol. 4 ml, 25 mg/ml , 1 fiol. 4 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Endometrial Neoplasms | MerckSharp&DohmeB.V. |
| Poland | (L01FF03) durvalumab | Imfinzi, koncentrat do sporządzania roztworu do infuzji, 50 mg/ml | 1 fiol.a 10 ml, 50 mg/ml , 1 fiol. 10 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB |
| Poland | (L01FF03) durvalumab | Imfinzi, koncentrat do sporządzania roztworu do infuzji, 50 mg/ml | 1 fiol.a 2,4 ml, 50 mg/ml , 1 fiol. 2,4 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | AstraZenecaAB |
| Poland | (L01FF05) atezolizumab | Tecentriq, koncentrat do sporządzania roztworu do infuzji, 1200 mg | 1 fiol.a 20 ml, 1200 mg , 1 fiol. 20 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheRegistrationGmbH |
| Poland | (L01FF05) atezolizumab | Tecentriq, koncentrat do sporządzania roztworu do infuzji, 840 mg | 1 fiol.a 14 ml, 840 mg , 1 fiol. 14 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma | RocheRegistrationGmbH |
Pages
